ASTRAL Score for Ischemic Stroke
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۱۲۰ • واحد: years
حداقل ۰ — حداکثر ۴۲ • واحد: points
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–15
- Moderate Risk16–25
- High Risk26–50
The ASTRAL Score for Ischemic Stroke calculates predicting 90-day poor outcome (mRS >2) in patients with acute ischemic stroke. Key inputs include age. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts 90-day poor outcome (mRS >2) in patients with acute ischemic stroke. The score combines age, NIHSS, timing, visual defects, glucose levels, and consciousness to stratify prognosis.
Clinical Indication
The ASTRAL Score for Ischemic Stroke is indicated for bedside clinical practice to support Predicts 90-day poor outcome (mRS >2) in patients with acute ischemic stroke. The score combines age, NIHSS, timing, visual defects, glucose levels, and consciousness to stratify prognosis.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.
Limitations & Contraindications
Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.
Clinical Pearls & Action Plan
Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility.
ASTRAL Score = Age + NIHSS + (2 if onset >3h) + (2 if visual field defect) + (1 if abnormal glucose) + (3 if impaired consciousness)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient age in years(years) |
| nihss_score | integer | Yes | National Institutes of Health Stroke Scale (NIHSS) score(points) |
| onset_to_admission_over_3h | string | Yes | More than 3 hours from symptom onset (or last time seen without stroke symptoms) to admission |
| visual_field_defect | string | Yes | Presence of any new visual field defect |
| abnormal_glucose | string | Yes | Admission glucose >131 mg/dL (7.3 mmol/L) or <66 mg/dL (3.7 mmol/L) |
| impaired_consciousness | string | Yes | Impaired consciousness at admission |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–15 | Low Risk | Lower probability of poor outcome |
| 16–25 | Moderate Risk | Moderate probability of poor outcome |
| 26–50 | High Risk | High probability of poor outcome |
Evidence-Based References (EBM)
- Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P. An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology. 2012;78(24):1916-22. doi: 10.1212/WNL.0b013e318259e221.DOI: 10.1212/WNL.0b013e318259e221
- Ntaios G, Gioulekas F, Papavasileiou V, Strbian D, Michel P. ASTRAL, DRAGON and SEDAN scores predict stroke outcome more accurately than physicians. Eur J Neurol. 2016;23(11):1651-1657. doi: 10.1111/ene.13100.DOI: 10.1111/ene.13100
- Liu G, Ntaios G, Zheng H, Wang Y, Michel P, Wang Y. External validation of the ASTRAL score to predict 3- and 12-month functional outcome in the China National Stroke Registry. Stroke. 2013;44(6):1443-50. doi: 10.1161/STROKEAHA.113.001047.DOI: 10.1161/STROKEAHA.113.001047